Outcomes of mitral valve surgery during concomitant aortic valve replacement.
Garrett N CoyanEdgar Aranda-MichelIbrahim S SultanThomas G GleasonForozan NavidDanny ChuMichael S SharbaughArman KilicPublished in: Journal of cardiac surgery (2018)
MVr can be performed during concomitant AVR without an adverse impact on longer-term outcomes, including mortality, re-admissions, and mitral reoperations. The majority of patients have durable repairs at 5 years although durability is less than that reported in isolated MVS.
Keyphrases
- mitral valve
- aortic valve replacement
- aortic stenosis
- ejection fraction
- end stage renal disease
- transcatheter aortic valve implantation
- left atrial
- aortic valve
- minimally invasive
- chronic kidney disease
- left ventricular
- transcatheter aortic valve replacement
- cardiovascular events
- preterm infants
- coronary artery bypass
- type diabetes
- emergency department
- risk factors
- heart failure
- adipose tissue
- skeletal muscle
- acute coronary syndrome
- insulin resistance
- percutaneous coronary intervention
- atrial fibrillation